Regulation of the murine inducible nitric oxide synthase gene by dexamethasone involves a heterogeneous nuclear ribonucleoprotein I (hnRNPI) dependent pathway

Molecular Immunology

Volumn 44, Issue 12, 2007, Pages 3204-3210

  Söderberg, Malin ^a   Raffalli Mathieu, Françoise ^a   Lang, Matti A ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

3 UTR; Dexamethasone; hnRNP; iNOS; mRNA stability; Post transcriptional regulation

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; GENE CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; RNA BINDING; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II;

MURINAE;

EID: 34247253736     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.01.029     Document Type: Article

References (33)

1. Ajizian S.J., English B.K., and Meals E.A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J. Infect. Dis. 179 (1999) 939-944
2. Chen C.Y., Xu N., and Shyu A.B. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15 (1995) 5777-5788
3. Di Rosa M., Radomski M., Carnuccio R., and Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 (1990) 1246-1252
4. Esnault S., Jarzembowski J.A., and Malter J.S. Stabilization of granulocyte-macrophage colony-stimulating factor RNA in a human eosinophil-like cell line requires the AUUUA motifs. Proc. Assoc. Am. Phys. 110 (1998) 575-584
5. Fechir M., Linker K., Pautz A., Hubrich T., Förstermann U., Rodriguez-Pascual F., and Kleinert H. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol. Pharmacol. 67 (2005) 2148-2161
6. Garcia-Gras E.A., Chi P., and Thompson E.A. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3'-untranslated region of the mRNA. J. Biol. Chem. 275 (2000) 22001-22008
7. Glisovic T., Söderberg M., Christian K., Lang M., and Raffalli-Mathieu F. Interplay between transcriptional and post-transcriptional regulation of Cyp2a5 expression. Biochem. Pharmacol. 65 (2003) 1653-1661
8. Jalonen U., Lahti A., Korhonen R., Kankaanranta H., and Moilanen E. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochem. Pharmacol. 69 (2005) 733-740
9. Jeon Y.J., Han S.H., Lee Y.W., Lee M., Yang K.H., and Kim H.M. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. Immunopharmacology 48 (2000) 173-183
10. Kim S.H., Kim J., and Sharma R.P. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol. Res. 49 (2004) 433-439
11. Kleinert H., Euchenhofer C., Ihrig-Biedert I., and Förstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Mol. Pharmacol. 49 (1996) 15-21
12. Korhonen R., Lahti A., Hämäläinen M., Kankaanranta H., and Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62 (2002) 698-704
13. Kunz D., Walker G., Eberhardt W., and Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 255-259
14. Lahti A., Jalonen U., Kankaanranta H., and Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol. Pharmacol. 64 (2003) 308-315
15. Lasa M., Brook M., Saklatvala J., and Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21 (2001) 771-780
16. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., and Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22 (2002) 7802-7811
17. Linker K., Pautz A., Fechir M., Hubrich T., Greeve J., and Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 33 (2005) 4813-4827
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Park S.K., and Murphy S. Nitric oxide synthase type II mRNA stability is translation- and transcription-dependent. J. Neurochem. 67 (1996) 1766-1769
20. Peppel K., Vinci J.M., and Baglioni C. The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173 (1991) 349-355
21. Radomski M.W., Palmer R.M., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 10043-10047
22. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S.A. 91 (1994) 752-756
23. Ristimäki A., Narko K., and Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318 Pt. 1 (1996) 325-331
24. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Förstermann U., and Kleinert H. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 275 (2000) 26040-26049
25. Saura M., Zaragoza C., Diaz-Cazorla M., Hernandez-Perera O., Eng E., Lowenstein C.J., Perez-Sala D., and Lamas S. Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int. 53 (1998) 38-49
26. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
27. Schoneveld O.J., Gaemers I.C., and Lamers W.H. Mechanisms of glucocorticoid signalling. Biochim. Biophys. Acta 1680 (2004) 114-128
28. Seiser C., Posch M., Thompson N., and Kuhn L.C. Effect of transcription inhibitors on the iron-dependent degradation of transferrin receptor mRNA. J. Biol. Chem. 270 (1995) 29400-29406
29. Söderberg M., Raffalli-Mathieu F., and Lang M.A. Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3'untranslated region of the murine inducible nitric-oxide synthase mRNA. Mol. Pharmacol. 62 (2002) 423-431
30. Söderberg M., Raffalli-Mathieu F., and Lang M.A. Identification of a regulatory cis-element within the 3'untranslated region of the murine inducible nitric-oxide synthase (iNOS) mRNA: interaction with heterogeneous nuclear ribonucleoproteins I and L and role in the iNOS gene expression. Mol. Immunol. 44 (2007) 434-442 (Epub 2006)
31. Vodovotz Y., Bogdan C., Paik J., Xie Q.W., and Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178 (1993) 605-613
32. Walker G., Pfeilschifter J., and Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J. Biol. Chem. 272 (1997) 16679-16687
33. Weisz A., Oguchi S., Cicatiello L., and Esumi H. Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J. Biol. Chem. 269 (1994) 8324-8333